Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1

Detalles Bibliográficos
Autores principales: Ruan, Qiao-ling, Wang, Zhi-chao, Wei, Cheng-jiang, Wang, Wei, Yang, Qing-luan, Wu, Jing, Wan, Yan-min, Ge, Ling-ling, Zhang, Wen-hong, Li, Qing-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236388/
https://www.ncbi.nlm.nih.gov/pubmed/37268605
http://dx.doi.org/10.1038/s41392-023-01498-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236388/
https://www.ncbi.nlm.nih.gov/pubmed/37268605
http://dx.doi.org/10.1038/s41392-023-01498-1

Ejemplares similares